Log in to save to my catalogue

15 Clinical profile of transthyretin amyloid cardiomyopathy patients in Ireland

15 Clinical profile of transthyretin amyloid cardiomyopathy patients in Ireland

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2580098437

15 Clinical profile of transthyretin amyloid cardiomyopathy patients in Ireland

About this item

Full title

15 Clinical profile of transthyretin amyloid cardiomyopathy patients in Ireland

Publisher

London: BMJ Publishing Group LTD

Journal title

Heart (British Cardiac Society), 2021, Vol.107 (Suppl 2), p.A16-A17

Language

English

Publication information

Publisher

London: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

BackgroundTransthyretin amyloid cardiomyopathy (ATTR-CM) is an under-recognised aetiology for heart failure with preserved ejection fraction. Early recognition and diagnosis of ATTR-CM should translate into better outcomes for these patients as targeted medications are licensed for use in ATTR-CM. European amyloid cardiomyopathy registries are esta...

Alternative Titles

Full title

15 Clinical profile of transthyretin amyloid cardiomyopathy patients in Ireland

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2580098437

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2580098437

Other Identifiers

ISSN

1355-6037

E-ISSN

1468-201X

DOI

10.1136/heartjnl-2021-ICS.15

How to access this item